Target intelligence / Profile preview

Otopetrin 1 (OTOP1)

Target
OTOP1
Molecular classification
Ion channel, proton-selective channel
01

Overview

Otopetrin 1 (OTOP1) is a dimeric transmembrane protein forming a proton-selective ion channel, comprised of 12 transmembrane segments organized into structurally similar N and C domains. OTOP1 is essential in mammals for two major physiological processes: sour taste perception (acting as the primary receptor for extracellular protons in taste buds) and otoconia biomineral formation in the inner ear, which is necessary for vestibular function. OTOP1 channel activity is regulated by extracellular pH and by key residues in extracellular loops, with its gating and permeation pathway still under active investigation. Structural studies reveal a unique channel architecture among ion channels, with lipid interactions that may modulate function. While not yet a therapeutic target, OTOP1's roles suggest potential relevance in sensory disorders and vestibular disease.

Other names
Proton channel OTOP1OTOP1hOtop1Otopetrin-1Otopetrin family protein
02

Mechanism of action

For inhibitors (like zinc ions): channel blockade leading to reduced proton currents. No approved drugs target OTOP1 clinically.

03

Biological functions

Sour taste transduction (taste perception)Otoconia formation in the inner ear (required for normal biomineral structure involved in vestibular sense)Proton conductance and pH sensing
04

Disease associations

Vestibular dysfunction (due to impaired otoconia formation)Potential involvement in taste disordersOther (OTOP1 roles in additional tissues and diseases are emerging but not fully defined)
05

Safety considerations

None documented in therapeutic contexts, partly because OTOP1 is not a current drug target.
06

Interacting drugs

None identified in current literature
07

Biomarkers

None established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Otopetrin 1 (OTOP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Otopetrin 1 (OTOP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call